Zonisamide
Back to searchMolecule Structure
Scientific Name
Zonisamide
Description of the Drug
Zonisamide is a sulfonamide anticonvulsant used to treat partial seizures.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00909
http://www.drugbank.ca/drugs/DB00909
Brand Name(s)
Zonegran, Zonisade, Zonisamide
Company Owner(s)
Glenmark Generics Inc Usa, Sun Pharmaceutical Industries Inc, Invagen Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Bionpharma Inc, Heritage Pharma Labs Inc Dba Avet Pharmaceuticals Labs Inc, Upsher Smith Laboratories Llc, Aurobindo Pharma Ltd, Ani Pharmaceuticals Inc, Azurity Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Sodium channel alpha subunit | PROTEIN FAMILY | BLOCKER | CHEMBL2331043 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL35458 | |
| PharmGKB | PA451978 | |
| Human Metabolome Database | HMDB0015045 | |
| DrugBank | DB00909 | |
| PubChem: Thomson Pharma | 15220241 | |
| PubChem | 11967800 | 5734 |
| Mcule | MCULE-1873297847 | |
| LINCS | LSM-3062 | |
| Nikkaji | J20.559A | |
| PDBe | ZON | |
| BindingDB | 50028010 | 10888 |
| EPA CompTox Dashboard | DTXSID9046023 | |
| DrugCentral | 2872 | |
| Brenda | 165533 | 1295 |
| ChemicalBook | CB0252441 | |
| Guide to Pharmacology | 7047 | |
| rxnorm | ZONISAMIDE | ZONEGRAN |
| PubChem: Drugs of the Future | 12012838 | |
| KEGG Ligand | C07504 | |
| ChEBI | 10127 | |
| ZINC | ZINC000000004321 |
